Article
PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease.
Neuroscience letters - 6 Nov 2006
Holzapfel Julia, Heun Reinhard, Lütjohann Dieter, Jessen Frank, Maier Wolfgang, Kölsch Heike
Abstract excerpt
Cholesterol metabolism is involved in Alzheimer's disease (AD) pathogenesis: increased cholesterol blood levels are detected in AD patients, and treatment with statins reduces the risk of AD. The peroxisome proliferator-activated receptor delta protein (PPARdelta), is a member of the steroid hormone super family of ligand-inducible transcription factors, and is of major relevance in lipid and cholesterol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
